000 01261 a2200337 4500
005 20250518013334.0
264 0 _c20200706
008 202007s 0 0 eng d
022 _a1098-1128
024 7 _a10.1002/med.21557
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNabergoj, Sanja
245 0 0 _aHarnessing the untapped potential of nucleotide-binding oligomerization domain ligands for cancer immunotherapy.
_h[electronic resource]
260 _bMedicinal research reviews
_c09 2019
300 _a1447-1484 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aLigands
650 0 4 _aNeoplasms
_xmetabolism
650 0 4 _aNod1 Signaling Adaptor Protein
_xchemistry
650 0 4 _aNod2 Signaling Adaptor Protein
_xchemistry
650 0 4 _aNucleotides
_xmetabolism
650 0 4 _aPolymerization
650 0 4 _aProtein Conformation
650 0 4 _aSignal Transduction
700 1 _aMlinarič-Raščan, Irena
700 1 _aJakopin, Žiga
773 0 _tMedicinal research reviews
_gvol. 39
_gno. 5
_gp. 1447-1484
856 4 0 _uhttps://doi.org/10.1002/med.21557
_zAvailable from publisher's website
999 _c29161805
_d29161805